Instituto de Química, Universidade de São Paulo, São Paulo, SP, Brazil.
Dalton Trans. 2013 May 14;42(18):6386-96. doi: 10.1039/c3dt00108c.
A set of four di-imine copper(II) complexes containing pyridine, pyrazine and/or imidazole moieties, Cu(apyhist)H2O 1 (apyhist = 2-(1H-imidazol-4-yl)-N-(1-(pyridin-2-yl)ethylidene)ethanamine), Cu(apzhist)OH 2 (apzhist = 2-(1H-imidazol-4-yl)-N-(1-(pyrazin-2-yl)ethylidene)ethanamine), Cu(apyepy)OH 3 (apyepy = 2-(pyridin-2-yl)-N-(1-(pyridin-2-yl)ethylidene)ethanamine), and Cu(apzepy)H2O 4 (apzepy = N-(1-(pyrazin-2-yl)ethylidene)-2-(pyridin-2-yl)ethanamine), were investigated regarding their capability of interacting with serum albumin (human, HSA and bovine, BSA), by using spectroscopic techniques, CD, UV/Vis and EPR. Like other similar di-imine copper(II) complexes, most of them showed an expected preferential insertion of the metal ion at the primary N-terminal site of the protein, very selective for copper and characterized by a CD band at 560 nm. Further insertion of the copper ion at a secondary site is expected when using an excess of the metal. However, one of these studied complexes, Cu(apyhist)H2O 1, exhibited anomalous behaviour interacting only at this secondary metal binding site of albumin, characterized by a CD band at 370 nm, and attributed to the coordination of copper at the Cys34 pocket. Analogous experiments with HSA previously treated with N-ethyl-maleimide (NEM), that oxidizes the protein Cys34 residue and obstructs the metal coordination, verified these results. Additional data obtained by EPR spectroscopy complemented those results. DFT calculations, considering some structural and electronic characteristics of such series of di-imine ligands and of the corresponding copper complexes, suggested molecular recognition of the apyhist ligand at the protein cavity as a feasible explanation for this unexpected and peculiar behaviour of complex 1.
一组包含吡啶、吡嗪和/或咪唑部分的四元二亚胺铜(II)配合物,Cu(apyhist)H2O 1(apyhist = 2-(1H-咪唑-4-基)-N-(1-(吡啶-2-基)亚乙基)乙胺),Cu(apzhist)OH 2(apzhist = 2-(1H-咪唑-4-基)-N-(1-(吡嗪-2-基)亚乙基)乙胺),Cu(apyepy)OH 3(apyepy = 2-(吡啶-2-基)-N-(1-(吡啶-2-基)亚乙基)乙胺),和Cu(apzepy)H2O 4(apzepy = N-(1-(吡嗪-2-基)亚乙基)-2-(吡啶-2-基)乙胺),通过光谱技术、CD、UV/Vis 和 EPR 研究了它们与血清白蛋白(人,HSA 和牛,BSA)相互作用的能力。与其他类似的二亚胺铜(II)配合物一样,它们大多数都表现出金属离子优先插入蛋白质的一级 N-末端位点的预期,对铜非常具有选择性,并且在 560nm 处具有 CD 带。当使用过量的金属时,预计会进一步插入铜离子到二级位点。然而,研究的这些配合物之一,Cu(apyhist)H2O 1,表现出异常行为,仅在白蛋白的这个二级金属结合位点相互作用,其特征是在 370nm 处具有 CD 带,归因于铜在 Cys34 口袋的配位。先前用 N-乙基-马来酰亚胺(NEM)处理 HSA 的类似实验氧化了蛋白质 Cys34 残基并阻碍了金属配位,验证了这些结果。通过 EPR 光谱获得的附加数据补充了这些结果。密度泛函理论(DFT)计算,考虑了此类二亚胺配体系列和相应铜配合物的一些结构和电子特性,表明了apyhist 配体在蛋白质腔中的分子识别是对配合物 1 这种意外和特殊行为的可行解释。